Proteros | GenomeWeb


NEW YORK (GenomeWeb News) – Illumina disclosed in its quarterly filing with the US Securities and exchange Commission that it paid a total consideration of $95.5 million for its acquisition of BlueGnome in July.

NEW YORK (GenomeWeb News) – Roche has selected the Alexandria Center for Life Science - New York City as the location for its Translational Clinical Research Center. The center will serve as the critical early development presence for Roche Pharma Research and Early Development in the US.

Under a deal announced today, Proteros will provide structures from its Gallery Structure catalogue of ready-to-use proteins for X-ray structure analysis of protein-ligand complexes, as well as gene-to-structure projects for novel biological targets.

The firm will provide the foundation with structure-based drug discovery services.

In the deal with the University of Cincinnati, Drug Discovery Center, Proteros will provide biotechnology and drug firms access to UC DCC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

The company will use its lead discovery service to study compounds for J&JPRD.

Movers & Shakers


Collin D'Silva, Albert Luderer, Timm Jessen, Dave Lemus, Robert Huber, Ingo Köhler, Berthold Hinzen, Andre Schmutte

The deal calls for Proteros to use its crystallography platform to decipher the X-ray structure of Axikin's protein, develop assays, identify active fragments, and develop the selected fragments into novel lead drug candidates.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.